140 related articles for article (PubMed ID: 3719594)
1. Enhancement of defective monocyte function during immunotherapy with recombinant interferon.
Nielsen H; Ernst P
Cancer Immunol Immunother; 1986; 22(2):144-7. PubMed ID: 3719594
[TBL] [Abstract][Full Text] [Related]
2. A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma.
Nielsen H; Bennedsen J; Larsen SO; Dombernowsky P; Viskum K
Cancer Immunol Immunother; 1982; 13(2):93-7. PubMed ID: 6297713
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of human monocyte cytotoxicity by both interferon-gamma and -beta and comparison to other stimuli.
Sharon N; Shoham J; Passwell JH
Int J Immunopharmacol; 1989; 11(7):743-9. PubMed ID: 2513281
[TBL] [Abstract][Full Text] [Related]
4. Influence of Bestatin, a new immunomodulator, on various functions of human monocytes.
Jarstrand C; Blomgren H
J Clin Lab Immunol; 1982 Dec; 9(3):193-8. PubMed ID: 7166751
[TBL] [Abstract][Full Text] [Related]
5. Suppression of blood monocyte and neutrophil chemotaxis in acute human malaria.
Nielsen H; Kharazmi A; Theander TG
Parasite Immunol; 1986 Nov; 8(6):541-50. PubMed ID: 3808753
[TBL] [Abstract][Full Text] [Related]
6. Effect of in vivo administration of interferon on human monocyte function.
Territo M; Sarna G; Figlin R
J Biol Response Mod; 1983; 2(5):450-7. PubMed ID: 6644349
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
9. The role of interferon-gamma in the immunotherapy of neuroblastoma.
Handgretinger R; Bruchelt G; Daurer B; Lang P; Herter M; Dopfer R; Müller B; Reisfeld RA; Treuner J; Niethammer D
Prog Clin Biol Res; 1991; 366():401-7. PubMed ID: 1906184
[No Abstract] [Full Text] [Related]
10. Decrease in the phagocytic activity of peripheral monocytes in patients treated with human interferon-alpha.
Einhorn S; Jarstrand C
Cancer Immunol Immunother; 1982; 13(3):149-52. PubMed ID: 6925979
[TBL] [Abstract][Full Text] [Related]
11. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
[TBL] [Abstract][Full Text] [Related]
12. Defective monocyte chemotaxis in pulmonary tuberculosis.
Nielsen H; Bennedsen J; Larsen SO; Rhodes JM; Viskum K
Eur J Respir Dis; 1982 Mar; 63(2):122-9. PubMed ID: 7067763
[TBL] [Abstract][Full Text] [Related]
13. Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.
Blomgren H
Cancer Immunol Immunother; 1989; 29(2):151-3. PubMed ID: 2720708
[TBL] [Abstract][Full Text] [Related]
14. Changes in immune function in patients receiving natural leukocyte interferon.
Maluish AE; Ortaldo JR; Sherwin SA; Oldham RK; Herberman RB
J Biol Response Mod; 1983; 2(5):418-27. PubMed ID: 6644346
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal recombinant alpha 2-interferon for 'salvage' immunotherapy in persistent epithelial ovarian cancer.
Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
Cancer Treat Rev; 1985 Dec; 12 Suppl B():23-32. PubMed ID: 3833327
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of natural killer cytotoxicity by alpha or gamma natural and recombinant interferons and interferon inducers. Effect of monocytes.
Platsoucas CD; Fernandes G; Good RA; Gupta S
Int Arch Allergy Appl Immunol; 1986; 79(1):1-7. PubMed ID: 3079737
[TBL] [Abstract][Full Text] [Related]
17. Thymostimulin administration modulates polymorph metabolic pathway in patients with chronic obstructive pulmonary disease.
Tortorella C; Ottolenghi A; Moretti AM; Jirillo E; Antonaci S
Immunopharmacol Immunotoxicol; 1992; 14(3):421-37. PubMed ID: 1325490
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.
Kerrebijn JD; Simons PJ; Tas M; Balm AJ; Drexhage HA
Eur Arch Otorhinolaryngol; 1995; 252(7):409-16. PubMed ID: 8562036
[TBL] [Abstract][Full Text] [Related]
19. [The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B].
Petrovskaia IA; Kushko LIa; Fedorchenko SV; Vovk AD; Listopad NK; Antoniak SN; Drannik GN
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):56-7. PubMed ID: 8553758
[No Abstract] [Full Text] [Related]
20. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
